FDA official logo
GSRS logoPFDA official logo

ETUVETIDIGENE AUTOTEMCEL

UNII:SMN5E7TJ9C
Formula:
Preferred Substance Name:ETUVETIDIGENE AUTOTEMCEL
GSRS Full Record:
SMN5E7TJ9C
i

  • AN AUTOLOGOUS CD34+ ENRICHED CELL POPULATION THAT CONTAINS CD34+ HSPC GENETICALLY MODIFIED EX VIVO USING A LENTIVIRAL VECTOR ENCODING THE HUMAN WAS GENE
  • AUTOLOGOUS CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPC), OBTAINED FROM BONE MARROW OR MOBILISED PERIPHERAL BLOOD. THE CELLS ARE TRANSDUCED EX VIVO WITH A SELF-INACTIVATING (SIN), REPLICATION-INCOMPETENT HUMAN IMMUNODEFICIENCY VIRUS 1 (HIV-1) BASED LENTIVIRAL VECTOR ENCODING THE WISKOTT-ALDRICH SYNDROME (WAS) PROTEIN UNDER THE CONTROL OF THE HUMAN WAS GENE 1.6 KB PROMOTER, THE VECTOR IS PSEUDOTYPED WITH THE VESICULAR STOMATITIS VIRUS (VSV) ENVELOPE GLYCOPROTEIN. THE VECTOR GENOME ALSO CONTAINS A MUTATED WOODCHUCK HEPATITIS VIRUS POST-TRANSCRIPTIONAL REGULATORY ELEMENT (WPRE), A FRAGMENT OF THE HIV-1 GAG, THE HIV-1 REV RESPONSE ELEMENT (RRE), THE HIV-1 CENTRAL POLYPURINE TRACT (CPPT) AND A FRAGMENT OF NEF. THE CD34+ CELL POPULATION CORRESPONDS TO AN HETEROGENOUS POPULATION OF STEM AND PROGENITOR CELLS, SOME EXPRESSING THE CD90 AND/OR CD133 MARKER
  • ETUVETIDIGENE AUTOTEMCEL [INN]
  • ETUVETIDIGENE AUTOTEMCEL [USAN]
  • GSK2696275
  • GSK-2696275
  • OTL 103 [WHO-DD]
  • OTL103
  • OTL-103
  • OTL-103 (AUTOLOGOUS CD34+ ENRICHED CELL FRACTION THAT CONTAINS CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS GENETICALLY MODIFIED EX VIVO USING A LENTIVIRAL VECTOR ENCODING THE HUMAN WISKOTT ALDRICH SYNDROME (WAS) CDNA SEQUENCE)
  • TELETHON003




UNII - SMN5E7TJ9C | UNII Search Service